Delivery Order SPE2DX15D1053-SPE2DX24F6MYQ
Award Date
5/29/24
Potential Completion Date
6/20/24
Potential Value
$3.5K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,323.84, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. This is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on July 2, 2024, with a completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $26,019.98, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the product "TECVAYLI 153 MG/1.7 ML VIAL 1.7ML" and has a completion date of April 10, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML medical supplies. The $3,809.92 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a civilian agency that provides medical products to the U.S. military and veterans' healthcare programs. The contract has an ultimate completion date of December 27, 2024 and was awarded on December 5, 2024. It is...
This federal contract award, valued at $59,560.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which is a Delivery Order, is for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a pharmaceutical product. The contract has a firm fixed price and a completion date of September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite Delivery...
This federal contract award is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML to the Defense Logistics Agency (DLA). The $23,824.28 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 16, 2024. The contract has an ultimate completion date of May 7, 2024 and is not set aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. The $17,802.18 firm fixed-price delivery order contract has a period of performance through February 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,912.14 firm fixed-price delivery order is for the drug TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, with a period of performance through December 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a...
This federal contract award, valued at $2,283.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tecvayli 30 mg/3 ml vials, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of February 7, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award....
This federal contract award, valued at $6,161.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract is a firm-fixed-price delivery order with a period of performance through December 31, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds several Indefinite Delivery Contracts (IDCs) with federal...